Review
Jul 2026
Long-Acting Lipoglycopeptide Treatment of Invasive Gram-Positive Infections
A narrative review, including the pharmacological characteristics of dalbavancin (DAL) and oritavancin (ORI), the only currently available laLGPs, as well as their approved and “off-label” use reported in the literature to date.
Madison E. Salam, D. Chastain, Douglas N. Fish et al.
· Drugs · 0 citations